Lani
03-20-2011, 09:24 PM
only brief treatment needed during just the right time, it seems!!!
2838 Brief exposure to gefitinib/Iressa during premalignant risk window provides lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice. Zhikun Ma, Yunbo Jiang, Shihe Yang, Stanley D. Kosanke, Xiaoshan Feng, XiaoHe Yang.
2838 Brief exposure to gefitinib/Iressa during premalignant risk window provides lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice. Zhikun Ma, Yunbo Jiang, Shihe Yang, Stanley D. Kosanke, Xiaoshan Feng, XiaoHe Yang.